Rat aldose reductase-like protein (AKR1B14) efficiently reduces the lipid peroxidation product 4-Oxo-2-nonenal

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 11, 2010, Pages 1886-1890

  Endo, Satoshi ^a   Matsunaga, Toshiyuki ^a   Fujita, Anna ^a   Tajima, Kazuo ^b   El Kabbani, Ossama ^c   Hara, Akira ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c MONASH UNIVERSITY   (Australia)

Author keywords

3 deoxyglucosone; 4 oxo 2 nonenal; AKR1B14; Aldo keto reductase; Aldose reductase inhibitor; Kinetic mechanism

Indexed keywords

3 DEOXYGLUCOSONE; 4 HEXENAL; 4 HYDROXYNONENAL; ACROLEIN; AKR1B14 PROTEIN; ALCOHOL DERIVATIVE; ALDEHYDE; ALDEHYDE REDUCTASE; EPALRESTAT; FARNESAL; HEXANAL; KETONE; METHYLGLYOXAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TOLRESTAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME SPECIFICITY; GENE EXPRESSION; GLYCATION; LIPID PEROXIDATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS;

ALCOHOL OXIDOREDUCTASES; ALDEHYDE REDUCTASE; ALDEHYDES; ANIMALS; BIOCATALYSIS; CATTLE; HUMANS; LIPID PEROXIDATION; LIVER; NADP; OXIDATIVE STRESS; RATS; SUBSTRATE SPECIFICITY;

EID: 78249267861     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.1886     Document Type: Article

References (40)

1. Mindnich R. D., Penning T. M., Hum. Genomics, 3, 362-370 (2009).
2. Barski O. A., Tipparaju S. M., Bhatnagar A., Drug Metab. Rev., 40, 553-624 (2008).
3. Yabe-Nishimura C., Pharmacol. Rev., 50, 21-33 (1998).
4. Oates P. J., Curr. Drug Targets, 9, 14-36 (2008).
5. Petrash J. M., Cell. Mol. Life Sci., 61, 737-749 (2004).
6. Jin Y., Penning T. M., Annu. Rev. Pharmacol. Toxicol., 47, 263-292 (2007).
7. Baba S. P., Barski O. A., Ahmed Y., O'Toole T. E., Conklin D. J., Bhatnagar A., Srivastava S., Diabetes, 58, 2486-2497 (2009).
8. Liu J., Wen G., Cao D., Recent Pat. Anticancer Drug Discov., 4, 246-253 (2009).
9. Cao D., Fan S. T., Chung S. S., J. Biol. Chem., 273, 11429-11435 (1998).
10. Martinez A., Aigueperse C., Val P., Dussault M., Tournaire C., Berger M., Veyssière G., Jean C., Lefrançois Martinez A., Chem. Biol. Interact., 130-132, 903-917 (2001).
11. Donohue P. J., Alberts G. F., Hampton B. S., Winkles J. A., J. Biol. Chem., 269, 8604-8609 (1994).
12. Lefrançois-Martinez A. M., Tournaire C., Martinez A., Berger M., Daoudal S., Tritsch D., Veyssière G., Jean C., J. Biol. Chem., 274, 32875-32880 (1999).
13. Srivastava S., Harter T. M., Chandra A., Bhatnagar A., Srivastava S. K., Petrash J. M., Biochemistry, 37, 12909-12917 (1998).
14. Kabututu Z., Manin M., Pointud J. C., Maruyama T., Nagata N., Lambert S., Lefrançois-Martinez A. M., Martinez A., Urade Y., J. Biochem., 145, 161-168 (2009).
15. Zeindl-Eberhart E., Klugbauer S., Dimitrijevic N., Jungblut P. R., Lamer S., Rabes H. M., Electrophoresis, 22, 3009-3018 (2001).
16. Val P., Martinez A., Sahut-Barnola I., Jean C., Veyssière G., Lefrançois-Martinez A. M., Endocrinology, 143, 3435-3448 (2002).
17. Endo S., Matsunaga T., Mamiya H., Hara A., Kitade Y., Tajima K., El- Kabbani O., Chem. Biol. Interact., 178, 151-157 (2009).
18. Battista M. C., Roberge C., Martinez A., Gallo-Payet N., Endocrinology, 150, 4180-4190 (2009).
19. Volle D. H., Repa J. J., Mazur A., Cummins C. L., Val P., Henry-Berger J., Caira F., Veyssiere G., Mangelsdorf D. J., Lobaccaro J. M., Mol. Endocrinol., 18, 888-898 (2004).
20. Liu M. J., Takahashi Y., Wada T., He J., Gao J., Tian Y., Li S., Xie W., Mol. Pharmacol., 76, 604-611 (2009).
21. Kotokorpi P., Gardmo C., Nyström C. S., Mode A., Endocrinology, 145, 5704-5713 (2004).
22. Jia G., Takahashi R., Zhang Z., Tsuji Y., Sone H., Int. J. Oncol., 29, 829-838 (2006).
23. Lambert-Langlais S., Pointud J. C., Lefrançois-Martinez A. M., Volat F., Manin M., Coudoré F., Val P., Sahut-Barnola I., Ragazzon B., Louiset E., Delarue C., Lefebvre H., Urade Y., Martinez A., PLoS One, 4, e7309 (2009).
24. Chung R., Endo S., Hara A., El-Kabbani O., Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun., 65, 395-397 (2009).
25. Doorn J. A., Maser E., Blum A., Claffey D. J., Petersen D. R., Biochemistry, 43, 13106-13114 (2004).
26. Tajima K., Hashizaki M., Yamamoto K., Mizutani T., Drug Metab. Dispos., 20, 816-820 (1992).
27. Matsuura K., Deyashiki Y., Bunai Y., Ohya I., Hara A., Arch. Biochem. Biophys., 328, 265-271 (1996).
28. Esterbauer H., Weger W., Monatsh. Chem., 98, 1994-2000 (1967).
29. Monder C., Furfine C. S., Methods Enzymol., 15, 667-675 (1969).
30. Tanaka N., Aoki K., Ishikura S., Nagano M., Imamura Y., Hara A., Nakamura K. T., Structure, 16, 388-397 (2008).
31. Usui S., Matsunaga T., Ukai S., Kiho T., Biosci. Biotechnol. Biochem., 61, 1924-1925 (1997).
32. Endo S., Matsunaga T., Mamiya H., Ohta C., Soda M., Kitade Y., Tajima K., Zhao H. T., El-Kabbani O., Hara A., Arch. Biochem. Biophys., 487, 1-9 (2009).
33. Crosas B., Hyndman D. J., Gallego O., Martras S., Parés X., Flynn T. G., Farrés J., Biochem. J., 373, 973-979 (2003).
34. Doorn J. A., Srivastava S. K., Petersen D. R., Chem. Res. Toxicol., 16, 1418-1423 (2003).
35. Shibata T., Iio K., Kawai Y., Shibata N., Kawaguchi M., Toi S., Kobayashi M., Kobayashi M., Yamamoto K., Uchida K., J. Biol. Chem., 281, 1196-1204 (2006).
36. Sato K., Inazu A., Yamaguchi S., Nakayama T., Deyashiki Y., Sawada H., Hara A., Arch. Biochem. Biophys., 307, 286-294 (1993).
37. Segel I.H., "Enzyme Kinetics," John Wiley and Sons, New York, 1975, pp. 505-845.
38. Dean P. D., Watson D. H., J. Chromatogr., 165, 301-319 (1979).
39. Martin H. J., Maser E., Chem. Biol. Interact., 178, 145-150 (2009).
40. Kuiper H. C., Langsdorf B. L., Miranda C. L., Joss J., Jubert C., Mata J. E., Stevens J. F., Free Radic. Biol. Med., 48, 65-72 (2010).